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Chidi Oguamanam †‡
Since Thomas Kuhn’s Structure of Scientific Revolutions, 1 philosophers and sociologists of science have
become bolder in questioning the purity or objectivity of
scientific claims. Science and technology continue to be
scrutinized in regard to their socio-cultural content and
their doubtful claims to neutrality. Critics and proponents of science are divided between the extremes of
‘‘scientific faithfuls’’ and ‘‘scientific skeptics’’ or Luddites.
For most scientific faithfuls, science is an unbridled pursuit of knowledge, with little regard to the consequences
of scientific and technological innovations on society
and social cohesion. Many sociologists and philosophers
of science, however, agree that science cannot be insulated from moral, political, and socio-cultural values that
constitute permanent features of all human activities.
Kitcher and Beck, for example, argue that science has no
monopoly on truth, and the interrelationship between
science and society requires making science accountable
to democratic and social values if we must realize ‘‘the
ideal of well-ordered science’’. 2
If the above references to Kitcher and Beck seem
distant, do not worry. In Biotechnology Unglued, Mehta
and his thirteen-member interdisciplinary team, comprising mainly of social scientists using a number of ‘‘case
studies’’, explore in nine essays ‘‘how advances in agricultural, medical, and forensic biotechnology may threaten
the social cohesiveness of different kinds of communities
and at different scales’’. 3 In a way, the project is a successful attempt to underscore the theme of (and imperative for) social accountability of science and
bio/technological innovations. This 208-page collection
of nine essays in a corresponding number of chapters is a
remarkable effort. It is a departure from the traditional
concerns regarding biotechnology innovations which,
hitherto, emphasized ethics, environmental sustainability, safety, human rights, equity, and global geo-

political tensions. These concerns are, however, not completely glossed over. They are implicated in the essayists’
analyses, but not at the expense of the book’s central
theme.
Mehta sets the tone in chapter one by situating the
essays that follow within the social cohesion theoretical
framework. He notes that social cohesion gauges ‘‘how
tightly coupled, robust, and unified a community is
across a set of indicators’’. 4 A socially cohesive community is resilient and most likely to adjust successfully and
to take advantage of developments or changes in society,
including biotechnology innovations. Because such a
community focuses on the interests of its members, it
does not necessarily address concerns about equity in
relation to less cohesive others. For Mehta, social cohesion can serve dual outcomes: ‘‘[I]t can work to ensure
that injustices are minimized’’. 5 Conversely, ‘‘[it] can support the conditions that allow injustices to remain
entrenched or even to develop more markedly’’. 6
Focusing on the promises and potential pitfalls of the
various forms of biotechnology in select communities,
the authors explore the technologies’ ramifications for
social cohesion of those communities. In mostly
embedded ways, they attempt to contrast socially cohesive communities that benefit from biotechnology, and
how biotechnology disrupts or ‘‘unglues’’ fragile or less
cohesive communities and thereby yields general inequity.
In chapter two, Mehta focuses on the impact of
biotechnology, especially the introduction of proprietary
genetically modified (GM) canola, on small-scale agricultural farming communities in Canada’s prime agricultural province of Saskatchewan. Because of the social
cohesiveness of large-scale farmers, they have been able
to take advantage of the introduction of herbicide-tol-
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erant crops and genetic modification in agriculture. A
combination of factors, including ready and integrated
industrial markets, strong capital outlay, sophisticated
manpower, and risk-benefit considerations, aided largescale farmers to make the transition to GM cropping.
However, this technology has the effect of eroding and
weakening small farming communities who are targets
of the new culture of surveillance imposed by proprietary right holders of patented transgenic materials. Also,
as part of its impact, agrobiotech practices de-skill small
farming communities by compromising their ability to
manage ecological or non-market stresses, engage in
seed-saving, and foster crop diversity. Mehta draws from
statistics evincing the recent rise in the percentage of
large-scale farmers in contrast to the decline of their
smaller counterparts, as well as increased incidence of
rural-urban drift among members of small farming communities since the advent of agrobiotech. From that
information, he concludes that such weakly cohesive
communities ‘‘are less able to muster and nurture ‘social
capital’ needed to sustain themselves’’ 7 in the era of biotechnology. Consequently, biotechnology is implicated
in the decline in the quality of life for traditional but
weakly cohesive agricultural communities in rural
western Canada. It is important to indicate that the conclusions of Mehta’s ‘‘case study’’ of Canada’s agricultural
belt holds true for the role of biotechnology on the
global geopolitical scale in terms of the North-South
dynamic.
Chapter three vindicates the last observation with
its focus on agrobiotech in developing countries and
global concerns about poverty alleviation, food security,
and sustainable development. It explores worldwide
trends in the biotechnology revolution and its promises
in regard to health, food, and the environment. The
authors of this chapter juxtapose the promises of modern
biotechnologies with their inherent disadvantages for
less cohesive and resource-poor farming communities in
the developing world. Adopting an ‘‘opportunities and
threats’’ paradigm, this chapter argues that the opportunities of agrobiotech ‘‘[have] so far been very much the
preserve of richer countries and to a lesser extent some
emerging economies’’ 8 at the expense of small-scale and
traditional farmers. This widening gap presents a threat
to social cohesiveness in developing countries. According
to the authors, this is so because agrobiotech research
hardly focuses on the needs of poor producers and consumers. In their view, what is needed is a double-shift in
the research paradigm to focus it on agro-ecological systems, and crops and other genetic resources critical to
people in developing countries. Such research needs
should ‘‘be contextualized within the broader socioeconomic and cultural situations of the poor and within a
deeper understanding of sustainable issues’’. 9 In order to
achieve this double-shift, the writers recommend the
adoption of interactive and participatory approaches.
Under this arrangement, which echoes Kitcher’s notion
of a well-ordered inquiry, developing countries must be
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active partners in shaping a biotechnology development
research agenda that is specifically targeted at the poor.
What the writers fail to realize, however, is that because
biotechnology research is conducted, for the most part,
outside the public funding framework, it is essentially
driven by commercial motives — a point that the concluding chapter affirms. Contrary to the authors’ suggestion, corporate stakeholders, rather than scholars, are in a
position to ensure the desired double-shift in the biotechnology research paradigm. Indeed, altruism is a
stranger in corporate boardrooms.
The next two chapters explore in two different contexts how the ‘‘legitimacy question’’ is a factor in the
introduction or non-introduction of genetically modified foods (GMFs) in two national consumer/citizen
communities of the US and Norway. In the US, loss of
confidence in regulatory authorities predated the introduction of GMFs. This trend was exacerbated in the
context of GM by the fundamental way in which it
‘‘alters the cultural frame in which food and society
issues are embedded’’. 10 In the US, government could
not be relied upon to convince consumers as to the
safety of GMFs. This is so because the closeness between
science, industry, and government in the regulation of
GMFs shows that government agencies are compromised and incompetent. The agencies are, in the words
of this chapter, ‘‘captured by the groups that they were
supposed to be administering’’. 11 Consequently, consumers’ general attitude to GMFs is one of skepticism.
They are now turned into ‘‘‘new Luddites’ who want to
break the movement of scientific progress in order to
return to a prescientific past characterized by minimalist
technology’’. 12 Thus, citizens and consumers demonstrate resistance to GMFs and seek to regain control by
shifting to organic and other alternative food. 13
As if in contrast to the trend in the US, and indeed
North America, chapter five 14 explores the procedural
pattern of the debate that led to a total rejection of GMFs
in Norway by consumers and citizens. Norway, to some
extent, is representative of the trend in Europe. In
Norway, two carefully selected lay panel conferences
backed by expert insights were organized as a modified
consensus development conference within a four-year
interval (1996 and 2000). They deliberated on the consequences and risks of introducing GMFs in Norway, and
their recommendation paved the way for the ban on
GMFs there. As in the US, the cultural frame in which
food is constructed is not one that GM addresses fully.
But the Norwegians were able to ensure that consumer
perception of food was not manipulated by a distrustful
regulatory authority that lacked legitimacy. By so doing,
Norwegian consumers averted the ‘‘exit’’ or resistance
measure that the US consumers adopted in regard to
GMFs. Indeed, unlike the US experience, Norway’s consensus on GMFs is informed by exceptional consumer
trust in government authorities. Such trust, Mehta insists
earlier, ‘‘is an essential component of socially cohesive
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society’’. 15 It also accounts for greater transparency and
translates, in Norway’s case, into the panel’s disposition
toward mandatory labeling for food containing GMsourced ingredients, a feat the US system could not
accomplish.
Chapter six shifts the previous chapters’ focus on
agriculture and food to health ramifications of biotechnology. It broaches Icelandic historical, political, geographical, and homogenous genealogical peculiarities.
These factors provided the unique set of circumstances
upon which Iceland’s biological, cultural, and social
cohesion is based. Consequently, Icelanders became the
source of a unique genetic database which, despite privacy and human rights concerns, the government was
able to commercialize in an arrangement with the USbased Decode Genetics. Access to Iceland’s genetic data
base is commercially attractive because its homogenous
nature facilities quicker identification of genetic traits
than would a nonhomogenous one. The author argues
that the Icelandic initiative reveals how a geographically
and culturally isolated and potentially endangered local
community could, through the wonders of biotechnology and the information society, facilitate therapeutic
strides with global ramifications. Even though the
chapter argues that this initiative is justified on medical
and economic grounds, perhaps its strongest implication
is captured in the author’s observation that it illustrates
the divorcing of culture and information ‘‘from a specific
place, experience and time’’ as a ‘‘global resource to be
mined through ‘bioprospecting’’’. 16 It creates a dynamic
in which biotechnology is implicated as an aspect of the
information society that ‘‘draws on the diversity and
cohesion of societies globally for very specific information to create competitive asymmetries’’. 17
Flipping over to the impact of biotechnology on the
Canadian justice system, chapter seven explores the
theme of biotechnology and social control. It discusses
broadly the place of DNA technology in the criminal
justice system and examines, specifically, why the introduction of a DNA data bank into the Canadian justice
system did not elicit much public scrutiny or resistance.
Clearly omitting the urgent desire for restoration of confidence in the criminal justice system, the author argues
that a combination of factors, including the fear of crime,
the emergence of a surveillance society, a redefinition of
criminality in favour of nature over nurture, and the
rationalization of the criminal justice system along a corporate model, account for the willingness of Canadian
society to accept, with little or no questioning, the risks
to human rights, privacy, and personal liberty posed by
this technology. According to the author, through biotechnology, the logic of ‘‘a genetically based justice
system’’ 18 or a justice system based on ‘‘biological determinism’’ 19 has ousted the traditional theory of crime
based on nurture. The risk-management potential of a
DNA data bank, in the eyes of the Canadian public,
appears to be a reasonable compromise for enhanced
genetic surveillance. 20
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Perhaps chapter eight stands out from the rest of the
contributions in regard both to its unique subject matter
and its analytical approach. It analogizes biotechnology
to ‘‘modern museums of civilization’’. With that imagery,
the authors argue that biotechnology is not radically
different from the 300 years of colonialism and the
politics of interpretation and mis/representation of the
colonized by members of the dominant society for
whom the present collection, classification, and commercialization of vital biological information is, in many
ways, akin to collection, arrangement, reification, and representation of museum artifacts. Implicating the
Human Genome Project and a couple of other
biotechnological initiatives, the writers argue that ‘‘biotechnology represents the appropriation of foreign and
exotic entities as genetic information in a dominant culture’s collection’’ 21 and their subjective interpretation
and valuation of that information. Unlike the activities of
early collectors of natural and cultural samples of
‘‘exotic’’ materials, biotechnology emphasizes the commercial exploitation of information with little or no
altruistic interest in domiciliation of knowledge in the
public domain. Picking on both the theme of globalization and resistance, this chapter concludes that even
though increasing globalization and monopolization of
information in the era of biotechnology forces people to
negotiate on the terms put forward by the dominant
interests, at the same time, there are extensive and wellorganized pockets of resistance and countermeasures to
genetic capitalization, distortion of cultural framings of
life, and undervaluation of diversity. 22
Reconnecting to the theme of social cohesion, this
time in regard to university research communities, the
last chapter 23 examines the hot button question of how
the multidisciplinary nature of biotechnology has
yielded an emerging collaborative research dynamics,
including syndicated R & D funding and tense competition over intellectual property in universities and corporate establishments. Re-echoing the theme of commercial emphasis in biotechnology development in this last
chapter, the writer associates the advent of biotechnology with the shift from the old Republic of Science
model to a new research dynamic. Supported mainly by
public funding, the former was curiosity-driven and
essentially disciplinary. The latter is ‘‘transdisciplinary
and problem-driven research structured around knowledge application’’, 24 and feeds on institutional arrangements and communication networks that link university, governments, and industry researchers/financiers.
The writers illustrate the new research dynamics by spotlighting the controversy surrounding Myriad Genetics,
Oncormed, University of Utah, and other clusters of
stakeholders in the US and Europe in the isolation of the
breast and ovarian cancer genes (BRACA1 and BRACA2)
and the intellectual property (patent) conflict on its trail.
With emphasis on an ‘‘opportunities and threats’’
paradigm, the chapter identifies some features of the
new research dynamics. They include greater emphasis
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on commercialization, the emergence of new actors, the
blurring of traditional organizational or practice frontiers
between private- and public-sector interests in research
and development, syndicated and increased funding
from multiple sources, bigger and more global research
consortiums or networks that encourage efficient utilization of expert knowledge, and purpose-driven and shortterm commitment to research. Among the major ‘‘side
effects’’ of these new research dynamics are questions
about ethics, conflict in research strategies and in the use
and allocation of research resources, human and material, and perhaps most importantly, conflicts about ownership of intellectual property rights and diffusion of
research results.
In all, this collection of essays is really an ambitious
project in disguise. It touches, in varying depths, many
contentious issues associated with biotechnologies in
their multidisciplinary essence. The essays are presented
in accessible language sufficiently filtered of disciplinary
jargons. Because of their accessibility, they provide a
primer on the subject for the ‘‘casually curious’’, as well
as fair intellectual, theoretical, and policy insights on specific subject matters for more probing readers. The book
is a welcome break from traditional criticisms of biotechnology and a shift to more engaging, thoughtful, and
practical analyses of its impact on social cohesion to
which many can relate.
However, there is little deliberate effort in each
chapter to tie the respective ‘‘case studies’’ to the theme
of social cohesion and to identify target communities.
For the most part, this connection is implied. After succinctly setting out the project’s theoretical thrust and
objective, Mehta appears to have permitted the contributors to determine for themselves if and to what extent
they would deliberately sustain the readers’ focus along
those lines. In the end, Mehta’s introductory chapter and
the second chapter prove to be extremely helpful for the
reader to make the required connection between the
subject of each chapter and the book’s general theme
and thesis. This connection is more easily made in some
chapters than others. For the most part, readers have to
identify for themselves what community or communities are implicated in each ‘‘case study’’, and to situate the
theme of social cohesion. This situation is not unusual
with a collection of essays in which the editor does not
have absolute power to ‘‘enforce strict compliance’’ with
the work’s conceptual framework as a sole writer would.
Given the diversity of focus among the chapters, the
editor may have had a tough challenge putting them
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together in some interrelated order. It may be noted,
however, that chapter five on the Norwegian GMF ‘‘case
study’’ would have made a perfect concluding chapter,
since it represents a successful approach in the management of the conflicting issues invoked by the biotechnology debate. Otherwise, each essay stands alone, even
though there is a thematic cohesion among them that is
aptly highlighted in the editor’s introduction.
In regard to the ‘‘case studies’’, it may be a little
inaccurate to classify each chapter as a case study in the
traditional or strict sense in which the term is associated
with field work and other matters of empirical detail.
However, for the most part, they focus on specific topics
within stated geographic confines. This way, they are
‘‘loose’’ forms of case studies. Readers would also be
challenged by the seeming ambiguous title of this work.
One gets the sense that the essays explore how biotechnology is complicit in ‘‘ungluing’’ or eroding the sociocultural dynamics of fragilely cohesive societies, rather
than how the vulnerabilities of these societies help to
expose or ‘‘unglue’’ biotechnology. I guess either interpretation could be correct. The first is more logical and
obvious from reading the book. But, on the face of it, the
title itself leans toward being read from the latter perspective.
As a multidisciplinary effort that tackles a fundamentally multidisciplinary subject matter like biotechnology, this book will be a helpful resource to persons
directly or remotely involved in biotechnology. For sociologists, philosophers of science, and those involved in
deliberative democracy and the challenges posed to
public policy by biotechnology and science in general, it
is interesting literature that engages critical areas of
public concern about the impact of biotechnology. For
lawyers, legal scholars, and members of interdisciplinary
research communities who are interested in ‘‘ungluing
biotechnology’’ for various reasons, this is an accessible
work that incorporates useful information on many
aspects of biotechnology from diverse sources and perspectives. This project, however, is not comprehensive in
its scope. For instance, subjects like intellectual property
rights; indigenous peoples and their knowledge, religion,
and beliefs systems; disability; gene therapy; and gene
profiling, to name a few, deserve a central place in a
project that explores biodiversity and social cohesion. In
appreciation of this, Mehta acknowledges that ‘‘this book
is only a starting point’’ 25 on its subject. It is a preliminary attempt at what portends to be a long and complex
conversation.
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